Riddiough M A
Drug Intell Clin Pharm. 1984 Jan;18(1):59-61. doi: 10.1177/106002808401800109.
There are two major issues that have potential for positive interactions between the industry and clinical pharmacy. These are drug selection and reimbursement, and clinical research. The first issue embodies the drug prescribing process, which has been, until recently, almost the sole purview of physicians. For this reason, pharmaceutical manufacturers have marketed their products primarily to this group. Changes are occurring; other licensed practitioners, including clinical pharmacists, are gaining prescribing authority. Schools of pharmacy have trained several thousand clinical pharmacists over the past decade, while the pharmacology component of medical education and the time devoted to clinical therapeutics either has stagnated or declined during the same period. Meanwhile, drug information has increased and the need to monitor drug selection to curtail costs has widened the opportunities for clinical pharmacists to exert an influence. The pharmaceutical industry needs to recognize the role clinical pharmacists play in drug selection. Drug selection decisions obviously influence drug reimbursement decisions, which influence drug sales, which influence profits. Clinical research is the backbone of a company's financial success and is becoming technologically sophisticated. Companies are becoming aware that many clinical pharmacists are able to collect and analyze clinical drug data as well as, or possibly better than, physicians. Clinical pharmacists can play a significant role in monitoring the safety and efficacy of marketed drugs. Good postmarketing surveillance data collection systems need to be developed.
制药行业与临床药学之间存在两个具有积极互动潜力的主要问题。这些问题是药物选择与报销以及临床研究。第一个问题体现了药物处方过程，直到最近，这几乎一直是医生的专属职责范围。因此，制药商主要向这一群体推销其产品。情况正在发生变化；包括临床药师在内的其他持牌从业者正在获得处方权。在过去十年中，药学院培养了数千名临床药师，而在此期间，医学教育中的药理学部分以及用于临床治疗学的时间要么停滞不前，要么有所下降。与此同时，药物信息有所增加，并且为控制成本而对药物选择进行监测的需求扩大了临床药师发挥影响的机会。制药行业需要认识到临床药师在药物选择中所起的作用。药物选择决策显然会影响药物报销决策，而药物报销决策又会影响药物销售，进而影响利润。临床研究是公司财务成功的支柱，并且在技术上正变得日益复杂。各公司逐渐意识到，许多临床药师在收集和分析临床药物数据方面的能力与医生相当，甚至可能比医生更好。临床药师在监测已上市药物的安全性和有效性方面可以发挥重要作用。需要建立良好的上市后监测数据收集系统。
